These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 20489069)

  • 1. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
    Koh DM; George C; Temple L; Collins DJ; Toomey P; Raja A; Bett N; Farhat S; Husband JE; Brown G
    AJR Am J Roentgenol; 2010 Jun; 194(6):W505-13. PubMed ID: 20489069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations.
    Koh DM; Brown G; Temple L; Raja A; Toomey P; Bett N; Norman AR; Husband JE
    Radiology; 2004 Apr; 231(1):91-9. PubMed ID: 14976266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer].
    Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria.
    Lahaye MJ; Engelen SM; Kessels AG; de Bruïne AP; von Meyenfeldt MF; van Engelshoven JM; van de Velde CJ; Beets GL; Beets-Tan RG
    Radiology; 2008 Mar; 246(3):804-11. PubMed ID: 18195379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
    Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
    Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
    Tokuhara T; Tanigawa N; Matsuki M; Nomura E; Mabuchi H; Lee SW; Tatsumi Y; Nishimura H; Yoshinaka R; Kurisu Y; Narabayashi I
    Gastric Cancer; 2008; 11(4):194-200. PubMed ID: 19132480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI: A New Reading Algorithm Based on Node-to-Node Matched Histopathology.
    Driessen DAJJ; Zámecnik P; Dijkema T; Pegge SAH; van Engen-van Grunsven ACH; Takes RP; Kaanders JHAM; Scheenen TWJ
    Invest Radiol; 2022 Dec; 57(12):810-818. PubMed ID: 35776432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
    Thoeny HC; Triantafyllou M; Birkhaeuser FD; Froehlich JM; Tshering DW; Binser T; Fleischmann A; Vermathen P; Studer UE
    Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer.
    Curvo-Semedo L; Diniz M; Miguéis J; Julião MJ; Martins P; Pinto A; Caseiro-Alves F
    J Magn Reson Imaging; 2006 Jul; 24(1):123-31. PubMed ID: 16755542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
    Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
    Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
    Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
    Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
    AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I
    J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.